In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Akili Interactive Labs

http://www.akiliinteractive.com/

Latest From Akili Interactive Labs

Kids, Time To Play Your Medicine: Akili Prepares Launch Of EndeavorRx Video Game For ADHD

After being first to receive FDA clearance for a prescription-only software to treat ADHD and raising total funding of $230m, Akili plans a US launch in 2022 while targeting other indications.

Digital Health Artificial Intelligence

Kids, Time To Play Your Medicine: Akili Prepares Launch Of EndeavorRx Video Game For ADHD

After being first to receive FDA clearance for a prescription-only software to treat ADHD and raising total funding of $230m, Akili plans a US launch in 2022 while targeting other indications.

Digital Health Neurology

CTA’s Standards For Digital Therapeutics Clears Up ‘Industry Confusion’

The Consumer Technology Association hopes its newly developed standard for digital therapeutics will clear up industry confusion and encourage the adoption of these treatments.

Digital Health Artificial Intelligence

Digital Health Roundup, August/September 2021: Record Digital Health Funding Q1-3 Of $21.3Bn, AAOS Highlights, Regulatory Updates

In this roundup of developments in digital health, we highlight the key news and announcements from August and September.

Digital Health Artificial Intelligence
See All

Company Information

  • Industry
  • Digital Health
  • Pharmaceuticals
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Monitoring Equipment & Devices
    • Rehabilitation Equipment and Devices
UsernamePublicRestriction

Register